TY - JOUR AU - Park, J. W. AU - Kim, M. PY - 2016 DA - 2016// TI - Replicating viruses for gynecologic cancer therapy JO - Eur J Gynaecol Oncol VL - 37 ID - Park2016 ER - TY - JOUR AU - Hartkopf, A. D. AU - Fehm, T. AU - Wallwiener, D. AU - Lauer, U. PY - 2011 DA - 2011// TI - Oncolytic virotherapy of gynecologic malignancies JO - Gynecol Oncol VL - 120 UR - https://doi.org/10.1016/j.ygyno.2010.10.031 DO - 10.1016/j.ygyno.2010.10.031 ID - Hartkopf2011 ER - TY - JOUR AU - Chan, W. M. AU - Rahman, M. M. AU - McFadden, G. PY - 2013 DA - 2013// TI - Oncolytic myxoma virus: the path to clinic JO - Vaccine VL - 31 UR - https://doi.org/10.1016/j.vaccine.2013.05.056 DO - 10.1016/j.vaccine.2013.05.056 ID - Chan2013 ER - TY - JOUR AU - Heiber, J. F. AU - Xu, X. X. AU - Barber, G. N. PY - 2011 DA - 2011// TI - Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer JO - Chin J Cancer VL - 30 UR - https://doi.org/10.5732/cjc.011.10205 DO - 10.5732/cjc.011.10205 ID - Heiber2011 ER - TY - JOUR AU - Matthews, K. S. AU - Alvarez, R. D. AU - Curiel, D. T. PY - 2009 DA - 2009// TI - Advancements in adenoviral based virotherapy for ovarian cancer JO - Adv Drug Deliv Rev VL - 61 UR - https://doi.org/10.1016/j.addr.2009.04.012 DO - 10.1016/j.addr.2009.04.012 ID - Matthews2009 ER - TY - JOUR AU - Benencia, F. AU - Coukos, G. PY - 2008 DA - 2008// TI - Biological therapy with oncolytic herpesvirus JO - Adv Exp Med Biol VL - 622 UR - https://doi.org/10.1007/978-0-387-68969-2_18 DO - 10.1007/978-0-387-68969-2_18 ID - Benencia2008 ER - TY - JOUR AU - Bauerschmitz, G. J. AU - Guse, K. AU - Kanerva, A. AU - Menzel, A. AU - Herrmann, I. AU - Desmond, R. A. PY - 2006 DA - 2006// TI - Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells JO - Mol Ther VL - 14 UR - https://doi.org/10.1016/j.ymthe.2006.01.010 DO - 10.1016/j.ymthe.2006.01.010 ID - Bauerschmitz2006 ER - TY - JOUR AU - Stoff-Khalili, M. A. AU - Dall, P. AU - Curiel, D. T. PY - 2004 DA - 2004// TI - From gene therapy to virotherapy for ovarian cancer JO - Minerva Ginecol VL - 56 ID - Stoff-Khalili2004 ER - TY - JOUR AU - Kanerva, A. AU - Zinn, K. R. AU - Chaudhuri, T. R. AU - Lam, J. T. AU - Suzuki, K. AU - Uil, T. G. PY - 2003 DA - 2003// TI - Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus JO - Mol Ther VL - 8 UR - https://doi.org/10.1016/S1525-0016(03)00200-4 DO - 10.1016/S1525-0016(03)00200-4 ID - Kanerva2003 ER - TY - JOUR AU - Rocconi, R. P. AU - Numnum, T. M. AU - Stoff-Khalili, M. AU - Makhija, S. AU - Alvarez, R. D. AU - Curiel, D. T. PY - 2005 DA - 2005// TI - Targeted gene therapy for ovarian cancer JO - Curr Gene Ther VL - 5 UR - https://doi.org/10.2174/156652305774964668 DO - 10.2174/156652305774964668 ID - Rocconi2005 ER - TY - JOUR AU - Hakkarainen, T. AU - Hemminki, A. AU - Pereboev, A. V. AU - Barker, S. D. AU - Asiedu, C. K. AU - Strong, T. V. PY - 2003 DA - 2003// TI - CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses JO - Clin Cancer Res VL - 9 ID - Hakkarainen2003 ER - TY - JOUR AU - Page, J. G. AU - Tian, B. AU - Schweikart, K. AU - Tomaszewski, J. AU - Harris, R. AU - Broadt, T. PY - 2007 DA - 2007// TI - Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-delta24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer JO - Am J Obstet Gynecol VL - 196 UR - https://doi.org/10.1016/j.ajog.2006.12.016 DO - 10.1016/j.ajog.2006.12.016 ID - Page2007 ER - TY - JOUR AU - Kelly, F. J. AU - Miller, C. R. AU - Buchsbaum, D. J. AU - Gomez-Navarro, J. AU - Barnes, M. N. AU - Alvarez, R. D. PY - 2000 DA - 2000// TI - Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro JO - Clin Cancer Res VL - 6 ID - Kelly2000 ER - TY - JOUR AU - Dmitriev, I. AU - Krasnykh, V. AU - Miller, C. R. AU - Wang, M. AU - Kashentseva, E. AU - Mikheeva, G. PY - 1998 DA - 1998// TI - An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism JO - J Virol VL - 72 ID - Dmitriev1998 ER - TY - JOUR AU - Suzuki, K. AU - Fueyo, J. AU - Krasnykh, V. AU - Reynolds, P. N. AU - Curiel, D. T. AU - Alemany, R. PY - 2001 DA - 2001// TI - A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency JO - Clin Cancer Res VL - 7 ID - Suzuki2001 ER - TY - JOUR AU - Kimball, K. J. AU - Preuss, M. A. AU - Barnes, M. N. AU - Wang, M. AU - Siegal, G. P. AU - Wan, W. PY - 2010 DA - 2010// TI - A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-0791 DO - 10.1158/1078-0432.CCR-10-0791 ID - Kimball2010 ER - TY - JOUR AU - Woller, N. AU - Gurlevik, E. AU - Ureche, C. I. AU - Schumacher, A. AU - Kuhnel, F. PY - 2014 DA - 2014// TI - Oncolytic viruses as anticancer vaccines JO - Front Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00188 DO - 10.3389/fonc.2014.00188 ID - Woller2014 ER - TY - JOUR AU - Lichty, B. D. AU - Breitbach, C. J. AU - Stojdl, D. F. AU - Bell, J. C. PY - 2014 DA - 2014// TI - Going viral with cancer immunotherapy JO - Nat Rev Cancer VL - 14 UR - https://doi.org/10.1038/nrc3770 DO - 10.1038/nrc3770 ID - Lichty2014 ER - TY - JOUR AU - Elsedawy, N. B. AU - Russell, S. J. PY - 2013 DA - 2013// TI - Oncolytic vaccines JO - Expert Rev Vaccines VL - 12 UR - https://doi.org/10.1586/14760584.2013.836912 DO - 10.1586/14760584.2013.836912 ID - Elsedawy2013 ER - TY - STD TI - Swift SL, Stojdl DF. Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy. Viruses. 2016;8(2):45. ID - ref20 ER - TY - JOUR AU - Forbes, N. E. AU - Krishnan, R. AU - Diallo, J. S. PY - 2014 DA - 2014// TI - Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses JO - Front Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00191 DO - 10.3389/fonc.2014.00191 ID - Forbes2014 ER - TY - JOUR AU - Li, X. AU - Mao, Q. AU - Wang, D. AU - Zhang, W. AU - Xia, H. PY - 2012 DA - 2012// TI - A fiber chimeric CRAd vector Ad5/11-D24 double-armed with TRAIL and arresten for enhanced glioblastoma therapy JO - Hum Gene Ther VL - 23 UR - https://doi.org/10.1089/hum.2011.130 DO - 10.1089/hum.2011.130 ID - Li2012 ER - TY - JOUR AU - Yang, S. W. AU - Chanda, D. AU - Cody, J. J. AU - Rivera, A. A. AU - Waehler, R. AU - Siegal, G. P. PY - 2011 DA - 2011// TI - Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0025131 DO - 10.1371/journal.pone.0025131 ID - Yang2011 ER - TY - JOUR AU - Cody, J. J. AU - Douglas, J. T. PY - 2009 DA - 2009// TI - Armed replicating adenoviruses for cancer virotherapy JO - Cancer Gene Ther VL - 16 UR - https://doi.org/10.1038/cgt.2009.3 DO - 10.1038/cgt.2009.3 ID - Cody2009 ER - TY - JOUR AU - Young, A. -. M. AU - Archibald, K. M. AU - Tookman, L. A. AU - Pool, A. AU - Dudek, K. AU - Jones, C. PY - 2012 DA - 2012// TI - Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo JO - Mol Ther VL - 20 UR - https://doi.org/10.1038/mt.2012.116 DO - 10.1038/mt.2012.116 ID - Young2012 ER - TY - JOUR AU - Wang, H. AU - Wei, F. AU - Zhang, J. AU - Wang, F. AU - Li, H. AU - Chen, X. PY - 2012 DA - 2012// TI - A novel immunocompetent murine tumor model for the evaluation of RCAd-enhanced RDAd transduction efficacy JO - Tumor Biol VL - 33 UR - https://doi.org/10.1007/s13277-012-0374-7 DO - 10.1007/s13277-012-0374-7 ID - Wang2012 ER - TY - JOUR AU - Kang, S. AU - Kim, J. -. H. AU - Kim, S. Y. AU - Kang, D. AU - Je, S. AU - Song, J. J. PY - 2014 DA - 2014// TI - Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus JO - Biochem Biophys Res Commun VL - 453 UR - https://doi.org/10.1016/j.bbrc.2014.09.107 DO - 10.1016/j.bbrc.2014.09.107 ID - Kang2014 ER - TY - JOUR AU - Gibson, H. AU - Munns, S. AU - Freytag, S. AU - Barton, K. AU - Veenstra, J. AU - Bettahi, I. PY - 2015 DA - 2015// TI - Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors JO - Oncoimmunology VL - 4 UR - https://doi.org/10.4161/2162402X.2014.984523 DO - 10.4161/2162402X.2014.984523 ID - Gibson2015 ER - TY - JOUR AU - Cheng, P. -. H. AU - Rao, X. -. M. AU - Wechman, S. L. AU - Li, X. -. F. AU - McMasters, K. M. AU - Zhou, H. S. PY - 2015 DA - 2015// TI - Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1731-x DO - 10.1186/s12885-015-1731-x ID - Cheng2015 ER - TY - JOUR AU - Jiang, H. AU - Clise-Dwyer, K. AU - Ruisaard, K. E. AU - Fan, X. AU - Tian, W. AU - Gumin, J. PY - 2014 DA - 2014// TI - Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0097407 DO - 10.1371/journal.pone.0097407 ID - Jiang2014 ER - TY - JOUR AU - Zhang, L. AU - Hedjran, F. AU - Larson, C. AU - Perez, G. AU - Reid, T. PY - 2015 DA - 2015// TI - A novel immunocompetent murine model for replicating oncolytic adenoviral therapy JO - Cancer Gene Ther VL - 22 UR - https://doi.org/10.1038/cgt.2014.64 DO - 10.1038/cgt.2014.64 ID - Zhang2015 ER - TY - JOUR AU - Al-Zaher, A. A. AU - Moreno, R. AU - Fajardo, C. A. AU - Arias-Badia, M. AU - Farrera, M. AU - Sostoa, J. PY - 2018 DA - 2018// TI - Evidence of anti-tumoral efficacy in an immune competent setting with an iRGD-modified hyaluronidase-armed oncolytic adenovirus JO - Molecular Therapy-Oncolytics VL - 8 UR - https://doi.org/10.1016/j.omto.2018.01.003 DO - 10.1016/j.omto.2018.01.003 ID - Al-Zaher2018 ER - TY - JOUR AU - Mo, L. AU - Bachelder, R. E. AU - Kennedy, M. AU - Chen, P. H. AU - Chi, J. T. AU - Berchuck, A. PY - 2015 DA - 2015// TI - Syngeneic murine ovarian Cancer model reveals that ascites enriches for ovarian Cancer stem-like cells expressing membrane GRP78 JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0579 DO - 10.1158/1535-7163.MCT-14-0579 ID - Mo2015 ER - TY - JOUR AU - Walton, J. AU - Blagih, J. AU - Ennis, D. AU - Leung, E. AU - Dowson, S. AU - Farquharson, M. PY - 2016 DA - 2016// TI - CRISPR/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high-grade serous carcinoma JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-16-1272 DO - 10.1158/0008-5472.CAN-16-1272 ID - Walton2016 ER - TY - JOUR AU - Fallaux, F. J. AU - Kranenburg, O. AU - Cramer, S. J. AU - Houweling, A. AU - Ormondt, H. AU - Hoeben, R. C. PY - 1996 DA - 1996// TI - Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors JO - Hum Gene Ther VL - 7 UR - https://doi.org/10.1089/hum.1996.7.2-215 DO - 10.1089/hum.1996.7.2-215 ID - Fallaux1996 ER - TY - JOUR AU - Egan, C. AU - Jelsma, T. N. AU - Howe, J. A. AU - Bayley, S. T. AU - Ferguson, B. AU - Branton, P. E. PY - 1988 DA - 1988// TI - Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5 JO - Mol Cell Biol VL - 8 UR - https://doi.org/10.1128/MCB.8.9.3955 DO - 10.1128/MCB.8.9.3955 ID - Egan1988 ER - TY - JOUR AU - Fueyo, J. AU - Gomez-Manzano, C. AU - Alemany, R. AU - Lee, P. S. AU - McDonnell, T. J. AU - Mitlianga, P. PY - 2000 DA - 2000// TI - A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo JO - Oncogene VL - 19 UR - https://doi.org/10.1038/sj.onc.1203251 DO - 10.1038/sj.onc.1203251 ID - Fueyo2000 ER - TY - JOUR AU - Heise, C. AU - Hermiston, T. AU - Johnson, L. AU - Brooks, G. AU - Sampson-Johannes, A. AU - Williams, A. PY - 2000 DA - 2000// TI - An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy JO - Nat Med VL - 6 UR - https://doi.org/10.1038/80474 DO - 10.1038/80474 ID - Heise2000 ER - TY - JOUR AU - Suzuki, K. AU - Alemany, R. AU - Yamamoto, M. AU - Curiel, D. T. PY - 2002 DA - 2002// TI - The presence of the adenovirus E3 region improves the oncolytic potency of conditionally replicative adenoviruses JO - Clin Cancer Res VL - 8 ID - Suzuki2002 ER - TY - JOUR AU - Kim, K. H. AU - Dmitriev, I. P. AU - Saddekni, S. AU - Kashentseva, E. A. AU - Harris, R. D. AU - Aurigemma, R. PY - 2013 DA - 2013// TI - A phase I clinical trial of Ad5/3-Delta24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer JO - Gynecol Oncol VL - 130 UR - https://doi.org/10.1016/j.ygyno.2013.06.003 DO - 10.1016/j.ygyno.2013.06.003 ID - Kim2013 ER - TY - JOUR AU - Fisher, P. B. AU - Sarkar, D. AU - Lebedeva, I. V. AU - Emdad, L. AU - Gupta, P. AU - Sauane, M. PY - 2007 DA - 2007// TI - Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma JO - Toxicol Appl Pharmacol VL - 224 UR - https://doi.org/10.1016/j.taap.2006.11.021 DO - 10.1016/j.taap.2006.11.021 ID - Fisher2007 ER - TY - JOUR AU - Guerillon, C. AU - Bigot, N. AU - Pedeux, R. PY - 2014 DA - 2014// TI - The ING tumor suppressor genes: status in human tumors JO - Cancer Lett VL - 345 UR - https://doi.org/10.1016/j.canlet.2013.11.016 DO - 10.1016/j.canlet.2013.11.016 ID - Guerillon2014 ER - TY - JOUR AU - Ashshi, A. M. AU - El-Shemi, A. G. AU - Dmitriev, I. P. AU - Kashentseva, E. A. AU - Curiel, D. T. PY - 2016 DA - 2016// TI - Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer JO - J Ovarian Res VL - 9 UR - https://doi.org/10.1186/s13048-016-0248-5 DO - 10.1186/s13048-016-0248-5 ID - Ashshi2016 ER - TY - JOUR AU - Krasnykh, V. AU - Belousova, N. AU - Korokhov, N. AU - Mikheeva, G. AU - Curiel, D. T. PY - 2001 DA - 2001// TI - Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin JO - J Virol VL - 75 UR - https://doi.org/10.1128/JVI.75.9.4176-4183.2001 DO - 10.1128/JVI.75.9.4176-4183.2001 ID - Krasnykh2001 ER - TY - JOUR AU - Maizel, J. V. AU - White, D. O. AU - Scharff, M. D. PY - 1968 DA - 1968// TI - The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12 JO - Virology VL - 36 UR - https://doi.org/10.1016/0042-6822(68)90121-9 DO - 10.1016/0042-6822(68)90121-9 ID - Maizel1968 ER - TY - JOUR AU - Mittereder, N. AU - March, K. L. AU - Trapnell, B. C. PY - 1996 DA - 1996// TI - Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy JO - J Virol VL - 70 ID - Mittereder1996 ER - TY - JOUR AU - Euhus, D. M. AU - Hudd, C. AU - LaRegina, M. C. AU - Johnson, F. E. PY - 1986 DA - 1986// TI - Tumor measurement in the nude mouse JO - J Surg Oncol VL - 31 UR - https://doi.org/10.1002/jso.2930310402 DO - 10.1002/jso.2930310402 ID - Euhus1986 ER - TY - JOUR AU - Tomayko, M. M. AU - Reynolds, C. P. PY - 1989 DA - 1989// TI - Determination of subcutaneous tumor size in athymic (nude) mice JO - Cancer Chemother Pharmacol VL - 24 UR - https://doi.org/10.1007/BF00300234 DO - 10.1007/BF00300234 ID - Tomayko1989 ER - TY - JOUR AU - Arap, W. AU - Pasqualini, R. AU - Ruoslahti, E. PY - 1998 DA - 1998// TI - Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model JO - Science VL - 279 UR - https://doi.org/10.1126/science.279.5349.377 DO - 10.1126/science.279.5349.377 ID - Arap1998 ER - TY - JOUR AU - Pasqualini, R. AU - Koivunen, E. AU - Ruoslahti, E. PY - 1997 DA - 1997// TI - Alpha v integrins as receptors for tumor targeting by circulating ligands JO - Nat Biotechnol VL - 15 UR - https://doi.org/10.1038/nbt0697-542 DO - 10.1038/nbt0697-542 ID - Pasqualini1997 ER - TY - JOUR AU - McCloskey, C. AU - Rodriguez, G. AU - Galpin, K. AU - Vanderhyden, B. PY - 2018 DA - 2018// TI - Ovarian cancer immunotherapy: preclinical models and emerging therapeutics JO - Cancers VL - 10 UR - https://doi.org/10.3390/cancers10080244 DO - 10.3390/cancers10080244 ID - McCloskey2018 ER - TY - JOUR AU - Janeway, C. A. AU - Medzhitov, R. PY - 2002 DA - 2002// TI - Innate immune recognition JO - Annu Rev Immunol VL - 20 UR - https://doi.org/10.1146/annurev.immunol.20.083001.084359 DO - 10.1146/annurev.immunol.20.083001.084359 ID - Janeway2002 ER - TY - JOUR AU - Zhou, F. PY - 2009 DA - 2009// TI - Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation JO - Int Rev Immunol VL - 28 UR - https://doi.org/10.1080/08830180902978120 DO - 10.1080/08830180902978120 ID - Zhou2009 ER - TY - JOUR AU - Kawai, T. AU - Akira, S. PY - 2010 DA - 2010// TI - The role of pattern-recognition receptors in innate immunity: update on toll-like receptors JO - Nat Immunol VL - 11 UR - https://doi.org/10.1038/ni.1863 DO - 10.1038/ni.1863 ID - Kawai2010 ER - TY - JOUR AU - Neefjes, J. AU - Jongsma, M. L. AU - Paul, P. AU - Bakke, O. PY - 2011 DA - 2011// TI - Towards a systems understanding of MHC class I and MHC class II antigen presentation JO - Nat Rev Immunol VL - 11 UR - https://doi.org/10.1038/nri3084 DO - 10.1038/nri3084 ID - Neefjes2011 ER - TY - JOUR AU - Li, Y. AU - Wang, L. X. AU - Yang, G. AU - Hao, F. AU - Urba, W. J. AU - Hu, H. M. PY - 2008 DA - 2008// TI - Efficient cross-presentation depends on autophagy in tumor cells JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0161 DO - 10.1158/0008-5472.CAN-08-0161 ID - Li2008 ER - TY - JOUR AU - Kim, K. H. AU - Ryan, M. J. AU - Estep, J. E. AU - Miniard, B. M. AU - Rudge, T. L. AU - Peggins, J. O. PY - 2011 DA - 2011// TI - A new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: the safety profile of ad5/3-Delta24 in advance of a phase I clinical trial in ovarian cancer patients JO - Hum Gene Ther VL - 22 UR - https://doi.org/10.1089/hum.2010.180 DO - 10.1089/hum.2010.180 ID - Kim2011 ER -